ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements
Kingfa filed CARE Ratings' monitoring report on its Rs.500 crore preferential issue proceeds. Nil deviation from issue objects was reported for the quarter ended September 30, 2026.
Kingfa Science & Technology filed a Q2 FY2026-27 performance update deck with greetings, market outlook and industry auto-production data. No revenue/profit table, order, or transaction is disclosed, so it is routine investor material.
Kingfa Science approved unaudited standalone results for the quarter and half year ended 30 September 2026. Half-year revenue from operations was ₹1,41,165.40 lakhs.
Kingfa disclosed that Nilima Ramrao Shinde ceased as Non-Executive Independent Director on tenure completion, effective 31 October 2026. No monetary value is involved.
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Kingfa Science & Technology (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b).
Kingfa Science & Technology (India) Ltd concluded its 42nd Annual General Meeting on September 28, 2026, where shareholders considered various business resolutions and financial statements.
Kingfa Science & Technology (India) Limited has submitted its Annual Report for the Financial Year 2025-26. The 42nd Annual General Meeting is scheduled for September 28, 2026.
Kingfa Science & Technology (India) Ltd is dispatching letters to shareholders providing instructions to access the Annual Report and Notice for its 42nd AGM.
Kingfa Science & Technology (India) Ltd has scheduled its 42nd Annual General Meeting on September 28, 2026, via video conferencing. The meeting includes dividend declaration proposals.
Kingfa Science & Technology announced a major board and leadership restructuring, involving several new appointments, resignations, and redesignations of directors and key managerial personnel.
Kingfa Science & Technology (India) Limited recommended a final dividend of ₹20 per equity share for the financial year 2025-2026. The payment is proposed by October 27, 2026.
Kingfa Science & Technology filed its quarterly Monitoring Agency Report for the period ended June 30, 2026, pursuant to SEBI regulatory requirements.
Kingfa Science & Technology (India) Ltd reported revenue from operations of ₹688.6 Cr (+49.1% YoY) and net profit of ₹80.2 Cr (+101.5% YoY) for Q1 FY27.
Kingfa Science & Technology (India) Limited has scheduled a board meeting for August 14, 2026. The board will consider Q1 financial results and final dividend recommendations.
Kingfa Science & Technology (India) Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. This standard regulatory disclosure details the company's equity ownership structure.
Kingfa Science & Technology (India) Ltd has filed its quarterly shareholding pattern as per SEBI regulations. This is a routine disclosure with no material corporate action.
Kingfa Science & Technology reported FY 2025-26 revenue of ₹1,995.55 Crore, a 14.38% year-on-year increase. Strong growth was driven by domestic sales and auto industry production.
Kingfa Science & Technology (India) Limited filed its Annual Secretarial Compliance Report for the financial year ending March 2026. The report confirms overall regulatory compliance with no deviations.
Kingfa Science & Technology (India) Ltd reported revenue from operations of ₹578.5 Cr (+23.2% YoY) and net profit of ₹59.1 Cr (+41.1% YoY) for Q4 FY26.
Kingfa Science reported full-year revenue of ₹1,995.55 Crore and net profit of ₹185.26 Crore. These audited results reflect significant annual growth and received an unmodified auditor opinion.
Kingfa Science & Technology scheduled a board meeting for May 29, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Kingfa Science & Technology (India) Limited utilized ₹40.63 Crore from preferential issue proceeds during Q4FY26. Funds were deployed for general corporate purposes with no deviations reported.
Kingfa Science & Technology (India) Limited has re-filed its standalone financial results for the quarter ended September 30, 2025. The revised XBRL filing corrects an inadvertent clerical error where 'Half Yearly' was previously selected instead of 'Second Quarter' in the reporting field. The correction ensures accurate regulatory reporting on the NSE portal.
Kingfa Science & Technology (India) Limited disclosed that it does not fall under the 'Large Corporate' category for FY 2025-26 as of March 31, 2026. The company reported zero outstanding borrowings and consequently has no mandatory debt-raising obligations under SEBI's Large Corporate framework.